- Home
- CRON vs DNA Comparison
CRON vs DNA Comparison
Compare CRON & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRON
- DNA
- Stock Information
- Founded
- CRON N/A
- DNA 2008
- Country
- CRON Canada
- DNA United States
- Employees
- CRON N/A
- DNA N/A
- Industry
- CRON Medicinal Chemicals and Botanical Products
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRON Health Care
- DNA Health Care
- Exchange
- CRON Nasdaq
- DNA Nasdaq
- Market Cap
- CRON 809.4M
- DNA 731.1M
- IPO Year
- CRON N/A
- DNA N/A
- Fundamental
- Price
- CRON $2.50
- DNA $11.15
- Analyst Decision
- CRON
- DNA Hold
- Analyst Count
- CRON 0
- DNA 2
- Target Price
- CRON N/A
- DNA $9.50
- AVG Volume (30 Days)
- CRON 4.2M
- DNA 1.7M
- Earning Date
- CRON 08-07-2025
- DNA 08-07-2025
- Dividend Yield
- CRON N/A
- DNA N/A
- EPS Growth
- CRON N/A
- DNA N/A
- EPS
- CRON 0.05
- DNA N/A
- Revenue
- CRON $130,282,000.00
- DNA $230,815,000.00
- Revenue This Year
- CRON $19.67
- DNA N/A
- Revenue Next Year
- CRON $30.56
- DNA $13.73
- P/E Ratio
- CRON $52.23
- DNA N/A
- Revenue Growth
- CRON 28.01
- DNA 25.21
- 52 Week Low
- CRON $1.60
- DNA $5.00
- 52 Week High
- CRON $2.77
- DNA $16.85
- Technical
- Relative Strength Index (RSI)
- CRON 55.55
- DNA 44.28
- Support Level
- CRON $2.47
- DNA $10.95
- Resistance Level
- CRON $2.71
- DNA $11.97
- Average True Range (ATR)
- CRON 0.11
- DNA 0.99
- MACD
- CRON -0.02
- DNA -0.20
- Stochastic Oscillator
- CRON 36.70
- DNA 17.02
About CRON Cronos Group Inc. Common Share
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.